The FDA has approved the Maestro Rechargeable System for treatment of obesity… The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight …

According to a new retrospective study acarbose may not have a cardioprotective effect as good as metformin when used as first-line therapy… This study analyzed 17,366 patients who initiated acarbose therapy and 230,023 who initiated metformin therapy. Both nephropathy and diabetes complication severity index were strongly associated with the patients …

In the study, the older athletes’ physical functions were more similar to that of young adults than of people their age… In a cross-sectional cohort study, researchers measured the relationship between age and physiological activity in healthy older individuals. The study included 84 male and 41 female cyclists aged 55 …

For every 0.56 mmol/L increase in fasting blood glucose there was a 14% increase in the rate of pancreatic cancer… In previous studies, an assumption has been made that diabetes may be either a risk factor or a symptom of pancreatic cancer. To investigate this connection, researchers examined both linear …

Low mood in healthy children is associated with poorer metabolic health independently of adiposity… Mood comprises two main traits – positive and negative affect, both associated with depression and anxiety. Studies in children have linked depression with obesity, but the association with metabolic health is unclear. Researchers from Plymouth University …

The association was also found to be stronger in younger women than in older women… Data from a large ongoing study into the health of African-American women show that those who work night shifts are significantly more likely to develop diabetes than those who have never worked night shifts, with …

Anemia is higher in older type 2 diabetes patients… The chances of an anemia diagnosis increase with age and it affects roughly about 10% of those 65 years of age or older. In diabetes patients, the probability of diagnosing anemia could be two to threefold higher and furthermore, from previous …

The new drug apparently works by stabilizing metabolites of an omega-3 fatty acid called DHA… Researchers Bruce Hammock at the University of California, Davis, and Joan Claria at the University of Barcelona found that an enzyme called soluble epoxide hydrolase, or sEH, inhibitor both prevented the onset of diabetes and …

Hypoglycemia was relatively uncommon in the ORIGIN (Outcome Reduction with an Initial Glargine Intervention) trial… ORIGIN trial investigators have published results of their look at treatment with insulin glargine compared with standard care early in the course of dysglycemia, and its effects on hypoglycemia. A total of 12,537 people with …

A longer duration of obesity also increased risk of colorectal cancer for diabetic patients… Dutch researchers have assessed the risk of colorectal cancer associated with type 2 diabetes, as compared with a nondiabetic reference population. They conducted an observational population-based cohort study within the Clinical Practice Research Datalink (1987–2012). All …